Fig. (1)
Kaplan-Meier curves of overall survival in patients with advanced lung cancer, dependent on the status of
(A)
ECOG performance status,
(B)
Presence or absence of
EGFR
mutations or
ALK
fusions,
(C)
Serum CYFRA21-1, and
(D)
Serum CEA.